EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Skin, gut, and lung barrier: Physiological interface and target of intervention for preventing and treating allergic diseases

Roberto Berni Canani iD, Marco Caminati iD, Laura Carucci iD, Ibon Eguiluz-Gracia iD

Allergy · 2024-06 · 79 (6) · 1485-1500

DOI: 10.1111/all.16092 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Allergy, online erschienen am 04.03.2024. Verfasst von Roberto Berni Canani und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Translational Medical Science, University of Naples Federico II, Naples, Italy. Hauptthemen laut MEDLINE: Hypersensitivity. Die Arbeit wurde bisher 87-mal zitiert (Crossref) und nennt 208 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Amgen, AstraZeneca.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The epithelial barriers of the skin, gut, and respiratory tract are critical interfaces between the environment and the host, and they orchestrate both homeostatic and pathogenic immune responses. The mechanisms underlying epithelial barrier dysfunction in allergic and inflammatory conditions, such as atopic dermatitis, food allergy, eosinophilic oesophagitis, allergic rhinitis, chronic rhinosinusitis, and asthma, are complex and influenced by the exposome, microbiome, individual genetics, and epigenetics. Here, we review the role of the epithelial barriers of the skin, digestive tract, and airways in maintaining homeostasis, how they influence the occurrence and progression of allergic and inflammatory conditions, how current treatments target the epithelium to improve symptoms of these disorders, and what the unmet needs are in the identification and treatment of epithelial disorders.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

HypersensitivityAnimalsHumansDisease ManagementDisease SusceptibilityGastrointestinal MicrobiomeLungSkinIntestinal Barrier Function

Stichwörter der Autor:innen

IL‐25IL‐33TSLPbiologicstight junctions

Autor:innen und Institutionen

  • Department of Translational Medical Science, University of Naples Federico II, Naples, Italy.
  • CEINGE Advanced Biotechnologies, University of Naples Federico II, Naples, Italy.
  • Allergy Unit and Asthma Centre, Verona Integrated University Hospital and Department of Medicine, University of Verona, Verona, Italy.
  • Allergy Unit, Hospital Regional Universitario de Malága, Malaga, Spain.
  • Allergy Group, Biomedical Research Institute of Malaga (IBIMA)-BIONAND Platform, RICORS Inflammatory Diseases, Malaga, Spain.

ORCID-Profile: Roberto Berni Canani, Marco Caminati, Laura Carucci, Ibon Eguiluz-Gracia

Förderung

  • Amgen
  • AstraZeneca

Zitieren

APA

Berni Canani, R., Caminati, M., Carucci, L., & Eguiluz-Gracia, I. (2024). Skin, gut, and lung barrier: Physiological interface and target of intervention for preventing and treating allergic diseases. Allergy, 79(6), 1485-1500. https://doi.org/10.1111/all.16092

Vancouver

Berni Canani R, Caminati M, Carucci L, Eguiluz-Gracia I. Skin, gut, and lung barrier: Physiological interface and target of intervention for preventing and treating allergic diseases. Allergy. 2024;79(6):1485-1500. doi:10.1111/all.16092

BibTeX
@article{BerniCanani2024,
  author = {Berni Canani, Roberto and Caminati, Marco and Carucci, Laura and Eguiluz-Gracia, Ibon},
  title = {Skin, gut, and lung barrier: Physiological interface and target of intervention for preventing and treating allergic diseases},
  journal = {Allergy},
  year = {2024},
  volume = {79},
  number = {6},
  pages = {1485--1500},
  doi = {10.1111/all.16092}
}
Kostenlos starten →